Fundraising Fox
/Companies
Sign in

Flexus Biosciences

San Carlos, US · Founded 2013 · Delaware corporation · 1 employees on LinkedIn · 2 known investors

Find your way into Flexus Biosciences

Sign up to see every warm intro you have to Flexus Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Flexus Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Creating cancer therapeutics through novel immunology insights; acquired by Bristol-Myers Squibb in April 2015 for $1.3B.

Biotech

Founders & leadership

Flexus Biosciences was founded in 2013 by Juan Carlos Jaen and Terry Rosen.

JC
Juan Carlos JaenPresident, Co-Founder & Head of R&D2013–2015Founder at Arcus Biosciences
TR
Terry RosenCo-founder · CEO2013–2015
LBLuis Bayol
Luis BayolInterim CFO2013–2015He has experience in start-up company consulting.

Board

BSBeth Seidenberg
Beth SeidenbergBoard directorFounding Managing Director at Westlake Village BioPartners
DG
Dave GoeddelBoard director
WR
William RieflinBoard director

Investors · 2

The Column Grouplisted by The Column GroupSan Francisco · $30M

How we know: The Column Group's portfolio page · funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$15.2M disclosed across 1 round · 2013

▶$15.2MraisedMar 2015 · 39 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Beth SeidenbergDirector
  • Luis BayolExecutive Officer
  • William RieflinDirector
  • Juan Carlos JaenExecutive Officer, Director
  • Terry RosenExecutive Officer, Director
  • Dave GoeddelDirector
Offering amount
$15.2M
Amount sold
$15.2M
First sale
Oct 2013
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Flexus Biosciences do?
Creating cancer therapeutics through novel immunology insights; acquired by Bristol-Myers Squibb in April 2015 for $1.3B.
Who founded Flexus Biosciences?
Flexus Biosciences was founded by Juan Carlos Jaen, Terry Rosen in 2013.
Who are Flexus Biosciences's investors?
Flexus Biosciences's investors include Kleiner Perkins, The Column Group.
How much funding has Flexus Biosciences raised?
Flexus Biosciences has disclosed $15.2M raised across 1 round.
Where is Flexus Biosciences headquartered?
Flexus Biosciences is headquartered in San Carlos, US.